Optovue Inc

Optovue Inc. is a privately held medical device company based in Fremont, California. Founded in 2003, the company employs 131 people and generates $20 million in annual revenue. Optovue specializes in developing and commercializing high-speed optical coherence tomography (OCT) and OCT angiography (OCTA) instruments. Optovue's products are designed to assist eye care professionals and clinical researchers in the diagnosis and management of various eye diseases. Their flagship product, the RTVue®, is a Fourier-domain (spectral domain) OCT system that provides ultra-high speed and high-resolution ocular imaging. This technology enables physicians to effectively diagnose and manage conditions such as macular degeneration, diabetic retinopathy, glaucoma, and anterior segment diseases. Optovue also offers a range of other OCT systems, including the iVue portable OCT, Avanti Widefield OCT, and AngioVue Imaging System, each catering to specific clinical needs. Optovue distinguishes itself through its commitment to innovation and collaboration. The company works closely with eye care professionals and clinical researchers to advance the field of OCT technology and improve patient care. Optovue's Scientific and Medical Advisory Board comprises leading experts in advanced OCT technology and ocular disease treatment, ensuring the company remains at the forefront of ophthalmic medical diagnostic imaging. For more information about Optovue and its products, please visit their website at optovue.com.